SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

10704	Companies
229038	Keywords
157682	Articles
121624	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 06/02/2025 at 07:00, 1 year 1 month ago

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease. Acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis and a promising pipeline in immunology

Acquisition Sanofi Rare Diseases Blueprint Medicines Immunological Disease
BRIEF

published on 05/30/2025 at 07:05, 1 year 1 month ago

Itepekimab Reaches Primary Endpoint in COPD Phase 3 Study

Sanofi COPD Regeneron Itepekimab AERIFY-1
PRESS RELEASE

published on 05/30/2025 at 07:00, 1 year 1 month ago

Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies
Itepekimab met primary endpoint in AERIFY-1 study for COPD, with significant reduction in exacerbations. AERIFY-2 did not meet endpoint. Sanofi and Regeneron assessing data for next steps

Sanofi COPD Regeneron Itepekimab AERIFY-1
BRIEF

published on 05/29/2025 at 14:35, 1 year 1 month ago

Positive impact of Beyfortus on hospitalizations due to RSV

Public Health Efficiency Beyfortus VRS Hospitalizations Childhood Vaccination
PRESS RELEASE

published on 05/29/2025 at 14:30, 1 year 1 month ago

Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs
Real-world comparison shows Beyfortus and RSVpreF immunization programs reduce infant RSV hospitalizations in Spain and UK. Beyfortus provides sustained protection against RSV with high efficacy and safety profile

RSV Beyfortus RSVpreF Infant Immunization
BRIEF

published on 05/22/2025 at 01:20, 1 year 1 month ago

Sanofi acquires Vigil Neuroscience to strengthen its Alzheimer's research

Acquisition Alzheimer's Disease Sanofi Neurology Vigil Neuroscience
PRESS RELEASE

published on 05/22/2025 at 01:15, 1 year 1 month ago

Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
Sanofi acquires Vigil Neuroscience to enhance neurology pipeline with an investigational medicine for Alzheimer's disease. The acquisition includes VG-3927, a small molecule TREM2 agonist

Alzheimer's Disease Sanofi Neurology Vigil Neuroscience VG-3927
BRIEF

published on 05/15/2025 at 19:11, 1 year 1 month ago

Sanofi: Details on Voting Rights and Shares - April 2025

Voting Rights Actions Investment Sanofi April 2025
BRIEF

published on 04/30/2025 at 13:05, 1 year 2 months ago

Sanofi and CD&R finalize the sale of Opella

Sanofi CD&R Assignment Opella Consumer Health
PRESS RELEASE

published on 04/30/2025 at 13:00, 1 year 2 months ago

Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
Sanofi and CD&R close Opella transaction, creating global consumer healthcare leader. Sanofi's sale of a 50.0% stake to CD&R marks a strategic move with total net cash proceeds of around €10 billion

Transaction Sanofi CD&R Consumer Healthcare Opella

Accesswire

Published on 07/10/2026 at 08:00, 2 hours 36 minutes ago

Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
Published on 07/10/2026 at 00:10, 10 hours 26 minutes ago

Core Silver and Arcus Enter Into Definitive Arrangement Agreement for Business Combination
Published on 07/10/2026 at 00:10, 10 hours 26 minutes ago

Core Silver and Arcus Enter Into Definitive Arrangement Agreement for Business Combination
Published on 07/09/2026 at 23:05, 11 hours 31 minutes ago

Caldwell Reports Third Quarter Results and Announces Increase of Quarterly Dividend
Published on 07/09/2026 at 22:30, 12 hours 6 minutes ago

Rio Grande Resources Announces Equity Grants

View all ACCESSWIRE

EQS Group

Published on 07/10/2026 at 10:28, 8 minutes ago

EQS-Adhoc: GRAMMER AG: Earnings in the second quarter of 2026 significantly above the previous year´s level
Published on 07/10/2026 at 10:13, 22 minutes ago

EQS-Adhoc: VINCORION SE: VINCORION revenue for the first half of 2026 is up significantly compared to the same period last year; full-year guidance confirmed
Published on 07/10/2026 at 10:05, 31 minutes ago

Original Software joins IFS partner program to help customers reduce cloud ERP change risk
Published on 07/10/2026 at 10:03, 32 minutes ago

HMS Bergbau AG: 2025/2030 corporate bond successfully increased by EUR 25 million
Published on 07/10/2026 at 10:03, 33 minutes ago

Halfords Group PLC: Director/PDMR Shareholding

Les Echos

Published on 07/09/2026 at 18:00, 16 hours 36 minutes ago

Second-quarter 2026 activity: +7% (vs. Q2 2025)
Published on 07/09/2026 at 18:00, 16 hours 36 minutes ago

Half-year report on Deezer’s liquidity contract with BNP Paribas
Published on 07/09/2026 at 17:45, 16 hours 51 minutes ago

Air Liquide to invest over 200M USD to support chemical manufacturing expansion in Texas
Published on 07/09/2026 at 15:50, 18 hours 45 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of June 30, 2026
Published on 07/09/2026 at 14:59, 19 hours 36 minutes ago

Liquidity contract

View all LES ECHOS COMFI WIRE